B. Ferko

发表

Azidothymidine inhibits melanoma cell growth in vitro and in vivo

H. Pehamberger, J. Humer, B. Ferko, 2008, Melanoma research.

Validation of the modified hemagglutination inhibition assay (mHAI), a robust and sensitive serological test for analysis of influenza virus-specific immune response.

T. Popow-Kraupp, B. Ferko, T. Muster, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Reepithelialization of experimental scalds effected by topically applied superoxide dismutase: controlled animal studies

H. Katinger, B. Ferko, K. Vorauer-Uhl, 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection

B. Ferko, I. Kuznetsova, K. Tabynov, 2014, Virology Journal.

A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.

T. Popow-Kraupp, B. Ferko, T. Muster, 2010, The Journal of infectious diseases.

Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet

D. Montefiori, B. Ferko, A. Rossi, 2012, International journal of molecular sciences.

Immunoglobulin G specifically binding plant N-glycans with high affinity could be generated in rabbits but not in mice.

N. Borth, B. Ferko, F. Altmann, 2006, Glycobiology.

Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A Viruses with Altered NS1 Genes

H. Katinger, B. Ferko, J. Romanova, 2004, Journal of Virology.

Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine

J. Oxford, A. Mann, B. Ferko, 2009, PloS one.

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

B. Ferko, T. Muster, M. Wolschek, 2015, PloS one.

Generation of an Influenza A Virus Vector Expressing Biologically Active Human Interleukin-2 from the NS Gene Segment

H. Katinger, B. Ferko, G. Stiegler, 2005, Journal of Virology.

Virus-coated layer-by-layer colloids as a multiplex suspension array for the detection and quantification of virus-specific antibodies.

Martin Fischlechner, B. Ferko, R. Grabherr, 2006, Clinical chemistry.

Hyperattenuated Recombinant Influenza A Virus Nonstructural-Protein-Encoding Vectors Induce Human Immunodeficiency Virus Type 1 Nef-Specific Systemic and Mucosal Immune Responses in Mice

H. Katinger, B. Ferko, J. Romanova, 2001, Journal of Virology.

Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans.

B. Ferko, T. Muster, A. Morokutti, 2014, Vaccine.

Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.

H. Katinger, B. Ferko, N. Bovin, 2003, Virology.

Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts

H. Katinger, B. Ferko, J. Romanova, 2006, Journal of Virology.

Live Attenuated Inﬂuenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts (cid:1)

H. Katinger, B. Ferko, J. Romanova, 2006 .

Sublingual Immunization with a Live Attenuated Influenza A Virus Lacking the Nonstructural Protein 1 Induces Broad Protective Immunity in Mice

B. Ferko, T. Muster, C. Czerkinsky, 2012, PloS one.

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

B. Ferko, T. Muster, M. Wolschek, 2015, PloS one.

Influenza Virus NS Vectors Expressing the Mycobacterium tuberculosis ESAT-6 Protein Induce CD4+ Th1 Immune Response and Protect Animals against Tuberculosis Challenge

H. Katinger, B. Ferko, M. Stukova, 2006, Clinical and Vaccine Immunology.

Hyperattenuated Recombinant Inﬂuenza A Virus Nonstructural-Protein-Encoding Vectors Induce Human Immunodeﬁciency Virus Type 1 Nef-Speciﬁc Systemic and Mucosal Immune Responses in Mice

H. Katinger, B. Ferko, J. Romanova, 2001 .

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein.

H. Katinger, B. Ferko, M. Stukova, 2006, Tuberculosis.

Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract.

H. Katinger, B. Ferko, T. Muster, 1998, The Journal of infectious diseases.

Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus

A. Trkola, H. Katinger, A. García-Sastre, 1995, Journal of virology.

Virus-Coated LbL Colloids as a Multiplex Suspension Array for the Detection and Quantification of Virus-Specific Antibodies

Martin Fischlechner, B. Ferko, R. Grabherr, 2006 .

Transfectant Influenza A Viruses with Long Deletions in the NS1 Protein Grow Efficiently in Vero Cells

H. Katinger, B. Ferko, T. Muster, 1998, Journal of Virology.

Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation.

H. Katinger, B. Ferko, K. Vorauer-Uhl, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.

H. Katinger, L. Eckhart, B. Ferko, 1996, The Journal of general virology.

Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis.

B. Ferko, F. Krammer, R. Grabherr, 2010, Journal of virological methods.

Establishment of a strategy for the rapid generation of a monoclonal antibody against the human protein SNEV (hNMP200) by flow-cytometric cell sorting.

H. Katinger, N. Borth, B. Ferko, 2005, Journal of immunological methods.

Effect of a single mutation in neuraminidase on the properties of Influenza B virus isolates

B. Ferko, J. Romanova, D. Katinger, 2003, Archives of Virology.

Swine‐origin pandemic H1N1 influenza virus‐like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice

B. Ferko, F. Krammer, R. Grabherr, 2010, Biotechnology journal.

Rescue of influenza virus expressing GFP from the NS1 reading frame.

H. Katinger, B. Ferko, J. Romanova, 2004, Virology.